| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019882 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019869 Chimeric neuropeptide Y receptors |
| 01/27/2005 | US20050019867 Alpha 1,4-galactosyl transferase and DNA encoding thereof |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019865 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 01/27/2005 | US20050019859 Mammalian ceII culture processes for protein production |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019819 DNA isolation method |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019801 Stem cell-based methods for identifying and characterizing agents |
| 01/27/2005 | US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019419 Biomaterial derived from vertebrate liver tissue |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019336 Human prostate cell lines in cancer treatment |
| 01/27/2005 | US20050019326 Antiinflammatory agents; tissue injury; autoimmune disease; anticancer agents |
| 01/27/2005 | US20050019324 Peptides and antibodies to muc 1 proteins |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019313 Genetic engineering; supplying stem cells; genes code cytosine deaminase; central nervous system tumors |
| 01/27/2005 | US20050019312 Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents |
| 01/27/2005 | US20050019311 For biological particles; encapsulated active materials |
| 01/27/2005 | US20050019310 Method for culturing and expansion of mammalian undifferentiated epidermal kerainocytes exhibiting stem cell characteristics |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | DE10331171A1 Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung Neutral protease (NP) and product using neutral protease for tissue dissociation as well as methods for its preparation |
| 01/27/2005 | DE10328280B3 Isolated, pluripotent adult stem cells, useful for treating injury or disease, e.g. tumors or diabetes, are isolated from exocrine gland tissue |
| 01/27/2005 | CA2536376A1 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | CA2535034A1 Internallly administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
| 01/27/2005 | CA2533121A1 Method of preparing langerhans cell from cd14-positive cell being human peripheral-blood mononuclear cell with use of notch ligand delta-1, gm-csf and tgf-.beta. |
| 01/27/2005 | CA2532781A1 The anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/27/2005 | CA2532630A1 Use of lymphocytes transformed with .alpha.-2-heremans-schmid glycoprotein (ahsg) to treat tgf-.beta.-mediated cancer |
| 01/27/2005 | CA2532323A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | CA2532216A1 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | CA2532138A1 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | CA2532127A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | CA2531565A1 Production of poxviruses with adherent or non adherent avian cell lines |
| 01/27/2005 | CA2527878A1 Antibodies and fusion proteins that include engineered constant regions |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/27/2005 | CA2525825A1 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500701A1 Cancer-associated gene mina 53, protein mina 53 and monoclonal antibody thereof |
| 01/26/2005 | EP1500699A1 Production of vaccinia virus with adherent or non adherent avian cell lines |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500697A2 Bioartifical, primarily vascularized tissue for pharmaceutical tests, method for its production, test using said tissue and use of it in a bioreactor. |
| 01/26/2005 | EP1500665A1 METHOD FOR CONSTRUCTING scDb LIBRARIES |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499885A2 Novel fusion proteins and assays for molecular binding |
| 01/26/2005 | EP1499742A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499735A2 Optimization of transgene expression in mammalian cells |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499727A1 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene |
| 01/26/2005 | EP1499726A1 Chimeric camp factors for vaccination against streptococcus infection |
| 01/26/2005 | EP1499725A1 Psp94 binding protein and psp94 diagnostic assays |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499718A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499716A1 Adh from rhodococcus erythropolis |
| 01/26/2005 | EP1499711A2 Method for preparing tissue constructs |
| 01/26/2005 | EP1499710A2 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 01/26/2005 | EP1499707A2 Enhancement of hematopoietic stem cell survival |
| 01/26/2005 | EP1499637A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 01/26/2005 | EP1499633A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 01/26/2005 | EP1499632A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499362A1 Fusions of cytokines and tumor targeting proteins |
| 01/26/2005 | EP1499353A2 Antibodies that specifically bind to tl5 |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499348A2 Multi plasmid system for the production of influenza virus |
| 01/26/2005 | EP1499340A2 Proteins involved in the regulation of energy homeostasis |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499181A2 Vascularized human skin equivalent |
| 01/26/2005 | EP1499180A2 Cancer models |
| 01/26/2005 | EP1499176A2 Novel vip3 toxins and methods of use |
| 01/26/2005 | EP1499175A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/26/2005 | EP1468094A4 Method of transducing es cells |
| 01/26/2005 | EP1446476A4 Endothelial cells derived from primate embryonic stem cells |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1334177B1 Generation and use of dendritic cells |
| 01/26/2005 | EP1315794A4 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 01/26/2005 | EP1207919B1 Humanized biomaterials containing monocytes or macrophages, a process for their preparation and their applications |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |
| 01/26/2005 | EP1092021B1 Npy-y7 receptor gene |
| 01/26/2005 | EP1073717A4 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 01/26/2005 | EP1015595B1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 01/26/2005 | EP0998555A4 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |